Starz is keeping the release date under wraps, but here’s the tea: filming for Season 8 wrapped in September 2024, and the cast finished post-production, like voiceovers and edits, by March 2025. If ...

Alright, Hazbin Hotel fans, let Ascend button and let’s dive into the chaos of Hell’s wildest hotel! Season 1 of Hazbin Hotel was a total banger—think catchy tunes, snarky demons, and a vibe that’s ...

If you’re a fan of Smiling Friends, the delightfully weird animated series from Zach Hadel and Michael Cusack, you’re probably itching for news about Season 3. This Adult Swim gem, packed with absurd ...

G’day, Heartbreak High fans! If you’re as obsessed with the Hartley High crew as we are, you’re probably itching to know what’s next after that wild Season 2 finale. The Aussie teen drama has us ...

Public sector bank (PSU) stocks were in focus after a Bloomberg report cited a Finance Ministry official stating that the Indian government may explore raising the foreign direct investment (FDI) cap ...

Okay, Grey’s Anatomy fans, let’s talk about Season 22! After that gut-punch of a Season 21 finale, I’m dying to know what’s next for our favorite doctors at Grey Sloan Memorial. The rumor mill is ...

Black Clover fans have been eagerly awaiting news about Season 5 since the anime went on hiatus in March 2021. With rumors swirling and excitement building, many are wondering: Is Black Clover Season ...

Man, Arcane hit us like a hextech bomb—gorgeous animation, characters that rip your heart out, and a story that keeps you glued to the screen. When Season 2 wrapped up on Netflix back in November 2024 ...

Emcure Pharmaceuticals Limited announced that its oncology manufacturing facility in Sanand, Ahmedabad has successfully cleared a Pre-Approval Inspection (PAI) conducted by the US Food and Drug ...

Biocon Limited has informed stock exchanges that its Board of Directors will meet on Thursday, August 7, 2025, to approve and take on record the unaudited standalone and consolidated financial results ...

Tata Elxsi shares gained nearly 1% in early trade on Thursday, climbing to a high of ₹6,174 on the NSE, as investors await the company’s Q1 FY26 earnings. The stock opened at ₹6,130 and touched an ...

In a major development for the biopharma space, Glenmark Pharmaceuticals’ US-based innovation arm, IGI Therapeutics SA, has entered into an exclusive licensing agreement with global pharma giant ...